Zentalis Pharmaceuticals lands $85 mln Series C

New York and San Diego-based Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company, has raised $85 million in Series C financing. The investors included Matrix Capital, Viking Global Investors, Redmile Group, Farallon Capital, Perceptive Advisors, Surveyor Capital and Eventide Asset Management

Source: Press Release